![Robert Hayes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert Hayes served as the Executive Director & Chief Scientific Officer at PYC Therapeutics Ltd. from 2017 to 2018.
Prior to that, he was the Senior Director-Protein Engineering at Johnson & Johnson (Austrial) Pty Ltd. and the Biologics Head at Amgen Australia Pty Ltd. Hayes holds a doctorate degree from Imperial College London and a graduate degree from University College London.
Ehemalige bekannte Positionen von Robert Hayes
| Unternehmen | Position | Ende |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2018 |
Johnson & Johnson (Austrial) Pty Ltd. | Corporate Officer/Principal | - |
Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
Ausbildung von Robert Hayes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Australia Pty Ltd. | |
Johnson & Johnson (Austrial) Pty Ltd. |
